Skip Navigation

European Journal of Heart Failure 2002 4(4):485-488; doi:10.1016/S1388-9842(02)00095-8
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mitchell, A. R.J.
Right arrow Articles by Sulke, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchell, A. R.J.
Right arrow Articles by Sulke, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2002 European Society of Cardiology

Reversal of tachycardiomyopathy by the atrial defibrillator

Andrew R.J. Mitchell*, Philip A.R. Spurrell, Huseyin Ahmet, Mike Higson and Neil Sulke

Department of Cardiology Eastbourne General Hospital, Kings Drive, BN21 2UD, Eastbourne, UK

* Corresponding author. Tel.: +44-1323-417400; fax: +44-1323-414993 E-mail address: mitcharj@doctors.org.uk

Key Words: Atrial fibrillation • Atrial defibrillator • Tachycardiomyopathy

Received September 28, 2001; Revised November 15, 2001; Accepted February 4, 2002

The first 10% of the full text of this article appears below.


   1. Introduction
 
It is increasingly recognized that the long-term consequences of atrial fibrillation (AF) are not benign. Chronic AF is associated with an increased mortality and a reduced life expectancy, believed to be as a consequence of thromboembolic disease (particularly stroke) and the onset of heart failure [1,2]. AF can result in both rapid and irregular ventricular rates and the development of atrial fibrillation-induced tachycardiomyopathy [3]. The evolution of the patient activated atrial defibrillator has empowered patients to ‘take charge’ of their condition and deliver an endocardial synchronised shock to restore sinus rhythm soon after the onset of arrhythmia [4]. We report . . . [Full Text of this Article]


   2. Report
 

   3. Discussion
 

   4. Conclusion
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?